Effects of intravenous administration of dexmedetomidine on intraocular pressure and pupil size in clinically normal dogs

Vet Ophthalmol. 2012 Mar:15 Suppl 1:79-82. doi: 10.1111/j.1463-5224.2011.00966.x. Epub 2011 Oct 31.

Abstract

Objective: To evaluate the effects of the intravenous administration of dexmedetomidine on the intraocular pressure (IOP) and pupil size (PS) in normal dogs.

Animals studied: Forty-two animals with no ocular abnormalities were included in this study.

Procedure: Following initial readings (T(0)) of IOP and PS, the dogs received an intravenous injection of dexmedetomidine (5 μg/kg). Both measurements were repeated 10 min (T(10) ) and 20 min (T(20)) later.

Results: There were no significant differences in IOP measurements between T(0) and T(10), although a significant decrease was observed at T(20). A significant miosis was found in the first 10 min after sedation. At T(20), the PS slightly increased, resulting in no statistical differences with T(0) and T(10).

Conclusion: Dexmedetomidine is an excellent option for surgery or diagnostic ocular procedures in dogs when a specific control of IOP is required. However, it must be used in combination with mydriatics in ophthalmic surgical or diagnostic procedures, which require complete dilation of the pupil.

Publication types

  • Clinical Trial

MeSH terms

  • Adrenergic alpha-2 Receptor Agonists / administration & dosage
  • Adrenergic alpha-2 Receptor Agonists / pharmacology
  • Animals
  • Dexmedetomidine / administration & dosage*
  • Dexmedetomidine / pharmacology*
  • Dogs*
  • Female
  • Injections, Intravenous
  • Intraocular Pressure / drug effects*
  • Male
  • Pupil / drug effects*

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Dexmedetomidine